YourLawyer.com® 1-800-LAW-INFO (1-800-529-4636)

Parker Waichman Alonso LLP Headlines by Topic

Aranesp

FDA panel wants more anemia drug studies

May 10, 2007 | AP
Two months after federal regulators ordered additional warnings be added to the labels of blockbuster anemia drugs, government advisers said Thursday...

FDA issues new warnings on anemia drugs

Mar 9, 2007 | AP
Federal health officials issued stern new warnings Friday for doctors to more carefully prescribe widely used anemia drugs that can increase the risk...

FDA Strengthens Safety Information for Erythropoiesis-Stimulating Agents (ESAs)

Mar 9, 2007 | www.fda.gov
The U.S. Food and Drug Administration (FDA) today issued a public health advisory outlining new safety information, including revised product...

FDA Warns of Serious Side Effects Related to Popular Anemia Drugs

Mar 9, 2007 | NewsInferno.com
FDA Warns of Serious Side Effects Related to Popular Anemia DrugsThe U.S. Food and Drug Administration (FDA) has issued a new warning about...

Amgen’s Anemia Drug Aranesp Carries Risk in Cancer Patients

Jan 29, 2007 | NewsInferno.com
In a letter sent last week to medical professionals and posted by the U.S. Food and Drug Administration (FDA), drug maker Amgen warned of an elevated...

Amgen’s Anemia Drug Aranesp Carries Risk in Cancer Patients

Jan 29, 2007 | NewsInferno.com
In a letter sent last week to medical professionals and posted by the U.S. Food and Drug Administration (FDA), drug maker Amgen warned of an elevated...

Amgen’s Anemia Drug Aranesp Carries Risk in Cancer Patients

Jan 29, 2007 | NewsInferno.com
In a letter sent last week to medical professionals and posted by the U.S. Food and Drug Administration (FDA), drug maker Amgen warned of an elevated...

Amgen’s Anemia Drug Aranesp Carries Risk in Cancer Patients

Jan 29, 2007 | NewsInferno.com
In a letter sent last week to medical professionals and posted by the U.S. Food and Drug Administration (FDA), drug maker Amgen warned of an elevated...

Aranesp (Darbepoetin Alfa) - Warnings Revised to Include Reports of Increased Mortality and Thrombotic Vascular Events

Jan 13, 2005 | www.pharmalive.com
FDA and Amgen notified healthcare professionals of revisions to the WARNINGS and PRECAUTIONS sections of the prescribing information for Aranesp,...

Page 3/3 [first] [prev] 1 2 3 [next] [last]

Aranesp
* Denotes required field.

Title

* First Name

* Last Name

* Email Address

* Phone Number

Cell Phone Number

Office Phone Number

Street Address

Apartment/Suite

City

State

Zip Code

Please provide the best method and times to contact you:

Date of birth of person injured
(mm-dd-yyyy):

Date you started taking the drug (mm-yyyy):

Date you stopped taking the drug (mm-yyyy):

Please describe any side effects:

Other Info:

No Yes, I agree to the Parker Waichman Alonso LLP disclaimers.Click here to review all.

Yes, I would like to receive the Parker Waichman Alonso LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.

Home | Defective Drugs | Medical Devices | Toxic Substances | Accidents | Product Liability | Malpractice | Diseases
Nursing Home Negligence | Food Poisoning | Other Topics | Social Security Disability | Contact
Statement of Clients' Rights | Site Map | Drug Injury Search | Vioxx | Mesothelioma | Permax | Dostinex | Composix Kugel Mesh X Large Patch
Ortho Evra | Fosamax | Personal Injury Lawyer | Fusarium Keratitis | Stevens Johnson Syndrome | Florida Personal Injury Law Firm

© 2002-2009 YourLawyer.com®. All Rights Reserved.

Please note that you are not considered a client until you have signed a retainer agreement and your case has been accepted by us.
Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Attorney Advertising

Parker Waichman Personal Injury News